▶ 調査レポート

世界の分子インフルエンザ検査市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Molecular Influenza Test Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の分子インフルエンザ検査市場規模・現状・予測(2021年-2027年) / Global Molecular Influenza Test Market Size, Status and Forecast 2021-2027 / QFJ1-4525資料のイメージです。• レポートコード:QFJ1-4525
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、分子インフルエンザ検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(RT-PCR、TMA、LAMP、NASBA、その他)、用途別市場規模(病院、臨床検査室、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・分子インフルエンザ検査の市場動向
・企業の競争状況、市場シェア
・分子インフルエンザ検査の種類別市場規模と予測2016-2027(RT-PCR、TMA、LAMP、NASBA、その他)
・分子インフルエンザ検査の用途別市場規模と予測2016-2027(病院、臨床検査室、その他)
・分子インフルエンザ検査の北米市場規模2016-2027(アメリカ、カナダ)
・分子インフルエンザ検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・分子インフルエンザ検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・分子インフルエンザ検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・分子インフルエンザ検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(F. Hoffmann-La Roche、Quidel Corporation、Thermo Fisher Scientific、Abbott Laboratories、Becton, Dickinson, and Company、DiaSorin、bioMérieux)
・結論

Rapid molecular assays are a kind of molecular influenza diagnostic test to detect influenza virus nucleic acids in upper respiratory tract specimens with high sensitivity (90-95%) and specificity. FDA-cleared rapid molecular assays are available that produce results in approximately 15-30 minutes. Some of these rapid molecular assays are CLIA-waived for point-of-care use.

Market Analysis and Insights: Global Molecular Influenza Test Market
The global Molecular Influenza Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Influenza Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Influenza Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Influenza Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Influenza Test market.

Global Molecular Influenza Test Scope and Market Size
Molecular Influenza Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Influenza Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
RT-PCR
TMA
LAMP
NASBA
Other

Segment by Application
Hospitals
Clinical Laboratories
Other End-User

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Becton, Dickinson, and Company
DiaSorin
bioMérieux

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Influenza Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 RT-PCR
1.2.3 TMA
1.2.4 LAMP
1.2.5 NASBA
1.2.6 Other
1.3 Market by Application
1.3.1 Global Molecular Influenza Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Other End-User
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Molecular Influenza Test Market Perspective (2016-2027)
2.2 Molecular Influenza Test Growth Trends by Regions
2.2.1 Molecular Influenza Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Influenza Test Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Influenza Test Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Influenza Test Industry Dynamic
2.3.1 Molecular Influenza Test Market Trends
2.3.2 Molecular Influenza Test Market Drivers
2.3.3 Molecular Influenza Test Market Challenges
2.3.4 Molecular Influenza Test Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Molecular Influenza Test Players by Revenue
3.1.1 Global Top Molecular Influenza Test Players by Revenue (2016-2021)
3.1.2 Global Molecular Influenza Test Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Influenza Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Influenza Test Revenue
3.4 Global Molecular Influenza Test Market Concentration Ratio
3.4.1 Global Molecular Influenza Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Influenza Test Revenue in 2020
3.5 Molecular Influenza Test Key Players Head office and Area Served
3.6 Key Players Molecular Influenza Test Product Solution and Service
3.7 Date of Enter into Molecular Influenza Test Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Influenza Test Breakdown Data by Type
4.1 Global Molecular Influenza Test Historic Market Size by Type (2016-2021)
4.2 Global Molecular Influenza Test Forecasted Market Size by Type (2022-2027)

5 Molecular Influenza Test Breakdown Data by Application
5.1 Global Molecular Influenza Test Historic Market Size by Application (2016-2021)
5.2 Global Molecular Influenza Test Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Molecular Influenza Test Market Size (2016-2027)
6.2 North America Molecular Influenza Test Market Size by Type
6.2.1 North America Molecular Influenza Test Market Size by Type (2016-2021)
6.2.2 North America Molecular Influenza Test Market Size by Type (2022-2027)
6.2.3 North America Molecular Influenza Test Market Size by Type (2016-2027)
6.3 North America Molecular Influenza Test Market Size by Application
6.3.1 North America Molecular Influenza Test Market Size by Application (2016-2021)
6.3.2 North America Molecular Influenza Test Market Size by Application (2022-2027)
6.3.3 North America Molecular Influenza Test Market Size by Application (2016-2027)
6.4 North America Molecular Influenza Test Market Size by Country
6.4.1 North America Molecular Influenza Test Market Size by Country (2016-2021)
6.4.2 North America Molecular Influenza Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Molecular Influenza Test Market Size (2016-2027)
7.2 Europe Molecular Influenza Test Market Size by Type
7.2.1 Europe Molecular Influenza Test Market Size by Type (2016-2021)
7.2.2 Europe Molecular Influenza Test Market Size by Type (2022-2027)
7.2.3 Europe Molecular Influenza Test Market Size by Type (2016-2027)
7.3 Europe Molecular Influenza Test Market Size by Application
7.3.1 Europe Molecular Influenza Test Market Size by Application (2016-2021)
7.3.2 Europe Molecular Influenza Test Market Size by Application (2022-2027)
7.3.3 Europe Molecular Influenza Test Market Size by Application (2016-2027)
7.4 Europe Molecular Influenza Test Market Size by Country
7.4.1 Europe Molecular Influenza Test Market Size by Country (2016-2021)
7.4.2 Europe Molecular Influenza Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Molecular Influenza Test Market Size (2016-2027)
8.2 Asia-Pacific Molecular Influenza Test Market Size by Type
8.2.1 Asia-Pacific Molecular Influenza Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Influenza Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Influenza Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Influenza Test Market Size by Application
8.3.1 Asia-Pacific Molecular Influenza Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Influenza Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Influenza Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Influenza Test Market Size by Region
8.4.1 Asia-Pacific Molecular Influenza Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Influenza Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Molecular Influenza Test Market Size (2016-2027)
9.2 Latin America Molecular Influenza Test Market Size by Type
9.2.1 Latin America Molecular Influenza Test Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Influenza Test Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Influenza Test Market Size by Type (2016-2027)
9.3 Latin America Molecular Influenza Test Market Size by Application
9.3.1 Latin America Molecular Influenza Test Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Influenza Test Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Influenza Test Market Size by Application (2016-2027)
9.4 Latin America Molecular Influenza Test Market Size by Country
9.4.1 Latin America Molecular Influenza Test Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Influenza Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Molecular Influenza Test Market Size (2016-2027)
10.2 Middle East & Africa Molecular Influenza Test Market Size by Type
10.2.1 Middle East & Africa Molecular Influenza Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Influenza Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Influenza Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Influenza Test Market Size by Application
10.3.1 Middle East & Africa Molecular Influenza Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Influenza Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Influenza Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Influenza Test Market Size by Country
10.4.1 Middle East & Africa Molecular Influenza Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Influenza Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Molecular Influenza Test Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Molecular Influenza Test Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Quidel Corporation
11.2.1 Quidel Corporation Company Details
11.2.2 Quidel Corporation Business Overview
11.2.3 Quidel Corporation Molecular Influenza Test Introduction
11.2.4 Quidel Corporation Revenue in Molecular Influenza Test Business (2016-2021)
11.2.5 Quidel Corporation Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Molecular Influenza Test Introduction
11.3.4 Thermo Fisher Scientific Revenue in Molecular Influenza Test Business (2016-2021)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Molecular Influenza Test Introduction
11.4.4 Abbott Laboratories Revenue in Molecular Influenza Test Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Becton, Dickinson, and Company
11.5.1 Becton, Dickinson, and Company Company Details
11.5.2 Becton, Dickinson, and Company Business Overview
11.5.3 Becton, Dickinson, and Company Molecular Influenza Test Introduction
11.5.4 Becton, Dickinson, and Company Revenue in Molecular Influenza Test Business (2016-2021)
11.5.5 Becton, Dickinson, and Company Recent Development
11.6 DiaSorin
11.6.1 DiaSorin Company Details
11.6.2 DiaSorin Business Overview
11.6.3 DiaSorin Molecular Influenza Test Introduction
11.6.4 DiaSorin Revenue in Molecular Influenza Test Business (2016-2021)
11.6.5 DiaSorin Recent Development
11.7 bioMérieux
11.7.1 bioMérieux Company Details
11.7.2 bioMérieux Business Overview
11.7.3 bioMérieux Molecular Influenza Test Introduction
11.7.4 bioMérieux Revenue in Molecular Influenza Test Business (2016-2021)
11.7.5 bioMérieux Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Molecular Influenza Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of RT-PCR
Table 3. Key Players of TMA
Table 4. Key Players of LAMP
Table 5. Key Players of NASBA
Table 6. Key Players of Other
Table 7. Global Molecular Influenza Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Molecular Influenza Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Molecular Influenza Test Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Molecular Influenza Test Market Share by Regions (2016-2021)
Table 11. Global Molecular Influenza Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Molecular Influenza Test Market Share by Regions (2022-2027)
Table 13. Molecular Influenza Test Market Trends
Table 14. Molecular Influenza Test Market Drivers
Table 15. Molecular Influenza Test Market Challenges
Table 16. Molecular Influenza Test Market Restraints
Table 17. Global Molecular Influenza Test Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Molecular Influenza Test Market Share by Players (2016-2021)
Table 19. Global Top Molecular Influenza Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Test as of 2020)
Table 20. Ranking of Global Top Molecular Influenza Test Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Molecular Influenza Test Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Molecular Influenza Test Product Solution and Service
Table 24. Date of Enter into Molecular Influenza Test Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Molecular Influenza Test Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Molecular Influenza Test Revenue Market Share by Type (2016-2021)
Table 28. Global Molecular Influenza Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Molecular Influenza Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Molecular Influenza Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Molecular Influenza Test Revenue Market Share by Application (2016-2021)
Table 32. Global Molecular Influenza Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Molecular Influenza Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Molecular Influenza Test Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Molecular Influenza Test Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Molecular Influenza Test Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Molecular Influenza Test Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Molecular Influenza Test Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Molecular Influenza Test Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Molecular Influenza Test Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Molecular Influenza Test Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Molecular Influenza Test Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Molecular Influenza Test Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Molecular Influenza Test Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Molecular Influenza Test Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Molecular Influenza Test Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Molecular Influenza Test Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Molecular Influenza Test Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Molecular Influenza Test Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Molecular Influenza Test Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Molecular Influenza Test Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Molecular Influenza Test Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Molecular Influenza Test Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Molecular Influenza Test Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Molecular Influenza Test Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Molecular Influenza Test Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Molecular Influenza Test Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Molecular Influenza Test Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Molecular Influenza Test Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Molecular Influenza Test Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Molecular Influenza Test Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Molecular Influenza Test Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Molecular Influenza Test Market Size by Country (2022-2027) & (US$ Million)
Table 64. F. Hoffmann-La Roche Company Details
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche Molecular Influenza Test Product
Table 67. F. Hoffmann-La Roche Revenue in Molecular Influenza Test Business (2016-2021) & (US$ Million)
Table 68. F. Hoffmann-La Roche Recent Development
Table 69. Quidel Corporation Company Details
Table 70. Quidel Corporation Business Overview
Table 71. Quidel Corporation Molecular Influenza Test Product
Table 72. Quidel Corporation Revenue in Molecular Influenza Test Business (2016-2021) & (US$ Million)
Table 73. Quidel Corporation Recent Development
Table 74. Thermo Fisher Scientific Company Details
Table 75. Thermo Fisher Scientific Business Overview
Table 76. Thermo Fisher Scientific Molecular Influenza Test Product
Table 77. Thermo Fisher Scientific Revenue in Molecular Influenza Test Business (2016-2021) & (US$ Million)
Table 78. Thermo Fisher Scientific Recent Development
Table 79. Abbott Laboratories Company Details
Table 80. Abbott Laboratories Business Overview
Table 81. Abbott Laboratories Molecular Influenza Test Product
Table 82. Abbott Laboratories Revenue in Molecular Influenza Test Business (2016-2021) & (US$ Million)
Table 83. Abbott Laboratories Recent Development
Table 84. Becton, Dickinson, and Company Company Details
Table 85. Becton, Dickinson, and Company Business Overview
Table 86. Becton, Dickinson, and Company Molecular Influenza Test Product
Table 87. Becton, Dickinson, and Company Revenue in Molecular Influenza Test Business (2016-2021) & (US$ Million)
Table 88. Becton, Dickinson, and Company Recent Development
Table 89. DiaSorin Company Details
Table 90. DiaSorin Business Overview
Table 91. DiaSorin Molecular Influenza Test Product
Table 92. DiaSorin Revenue in Molecular Influenza Test Business (2016-2021) & (US$ Million)
Table 93. DiaSorin Recent Development
Table 94. bioMérieux Company Details
Table 95. bioMérieux Business Overview
Table 96. bioMérieux Molecular Influenza Test Product
Table 97. bioMérieux Revenue in Molecular Influenza Test Business (2016-2021) & (US$ Million)
Table 98. bioMérieux Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Influenza Test Market Share by Type: 2020 VS 2027
Figure 2. RT-PCR Features
Figure 3. TMA Features
Figure 4. LAMP Features
Figure 5. NASBA Features
Figure 6. Other Features
Figure 7. Global Molecular Influenza Test Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinical Laboratories Case Studies
Figure 10. Other End-User Case Studies
Figure 11. Molecular Influenza Test Report Years Considered
Figure 12. Global Molecular Influenza Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Molecular Influenza Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Molecular Influenza Test Market Share by Regions: 2020 VS 2027
Figure 15. Global Molecular Influenza Test Market Share by Regions (2022-2027)
Figure 16. Global Molecular Influenza Test Market Share by Players in 2020
Figure 17. Global Top Molecular Influenza Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Test as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Molecular Influenza Test Revenue in 2020
Figure 19. Global Molecular Influenza Test Revenue Market Share by Type (2016-2021)
Figure 20. Global Molecular Influenza Test Revenue Market Share by Type (2022-2027)
Figure 21. North America Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Molecular Influenza Test Market Share by Type (2016-2027)
Figure 23. North America Molecular Influenza Test Market Share by Application (2016-2027)
Figure 24. North America Molecular Influenza Test Market Share by Country (2016-2027)
Figure 25. United States Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Molecular Influenza Test Market Share by Type (2016-2027)
Figure 29. Europe Molecular Influenza Test Market Share by Application (2016-2027)
Figure 30. Europe Molecular Influenza Test Market Share by Country (2016-2027)
Figure 31. Germany Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Molecular Influenza Test Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Molecular Influenza Test Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Molecular Influenza Test Market Share by Region (2016-2027)
Figure 41. China Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Molecular Influenza Test Market Share by Type (2016-2027)
Figure 49. Latin America Molecular Influenza Test Market Share by Application (2016-2027)
Figure 50. Latin America Molecular Influenza Test Market Share by Country (2016-2027)
Figure 51. Mexico Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Molecular Influenza Test Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Molecular Influenza Test Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Molecular Influenza Test Market Share by Country (2016-2027)
Figure 57. Turkey Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Molecular Influenza Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Molecular Influenza Test Business (2016-2021)
Figure 61. Quidel Corporation Revenue Growth Rate in Molecular Influenza Test Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Molecular Influenza Test Business (2016-2021)
Figure 63. Abbott Laboratories Revenue Growth Rate in Molecular Influenza Test Business (2016-2021)
Figure 64. Becton, Dickinson, and Company Revenue Growth Rate in Molecular Influenza Test Business (2016-2021)
Figure 65. DiaSorin Revenue Growth Rate in Molecular Influenza Test Business (2016-2021)
Figure 66. bioMérieux Revenue Growth Rate in Molecular Influenza Test Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed